Julie Sahler

952 total citations
25 papers, 520 citations indexed

About

Julie Sahler is a scholar working on Immunology, Hematology and Infectious Diseases. According to data from OpenAlex, Julie Sahler has authored 25 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Hematology and 5 papers in Infectious Diseases. Recurrent topics in Julie Sahler's work include Immune Cell Function and Interaction (6 papers), Platelet Disorders and Treatments (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Julie Sahler is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Platelet Disorders and Treatments (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Julie Sahler collaborates with scholars based in United States, France and India. Julie Sahler's co-authors include Richard P. Phipps, Neil Blumberg, Sherry L. Spinelli, Katie L. Lannan, Nina Kim, S. Spinelli, Sesquile Ramon, Luis Martínez‐Sobrido, David J. Topham and Eric Feldsott and has published in prestigious journals such as ACS Nano, The Journal of Immunology and PLoS ONE.

In The Last Decade

Julie Sahler

23 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Sahler United States 11 143 138 117 112 71 25 520
U.J. Dumaswala United States 15 214 1.5× 152 1.1× 160 1.4× 53 0.5× 413 5.8× 28 703
Rufeng Xie China 13 29 0.2× 85 0.6× 173 1.5× 178 1.6× 38 0.5× 30 496
Yanxia Sun China 11 50 0.3× 74 0.5× 352 3.0× 51 0.5× 8 0.1× 32 538
Mohammad Reza Deyhim Iran 8 88 0.6× 41 0.3× 69 0.6× 10 0.1× 50 0.7× 27 317
Narinder Gautam Sweden 7 16 0.1× 55 0.4× 163 1.4× 218 1.9× 102 1.4× 8 627
Laszlo Leb United States 11 36 0.3× 84 0.6× 117 1.0× 65 0.6× 277 3.9× 14 532
Su Zhang Sweden 14 14 0.1× 75 0.5× 187 1.6× 308 2.8× 35 0.5× 16 647
Wayne M. Flye United States 12 47 0.3× 21 0.2× 71 0.6× 101 0.9× 20 0.3× 17 475
Arnaud Ferraris Italy 11 21 0.1× 60 0.4× 87 0.7× 43 0.4× 20 0.3× 27 350
Tomoaki Doi Japan 13 18 0.1× 75 0.5× 174 1.5× 70 0.6× 51 0.7× 52 466

Countries citing papers authored by Julie Sahler

Since Specialization
Citations

This map shows the geographic impact of Julie Sahler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Sahler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Sahler more than expected).

Fields of papers citing papers by Julie Sahler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Sahler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Sahler. The network helps show where Julie Sahler may publish in the future.

Co-authorship network of co-authors of Julie Sahler

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Sahler. A scholar is included among the top collaborators of Julie Sahler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Sahler. Julie Sahler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buchholz, David W., Suresh Poosala, Vangala Subrahmanyam, et al.. (2025). Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in mice. Biochemical and Biophysical Research Communications. 753. 151480–151480. 1 indexed citations
2.
Limper, Candice, C. Silliman, Amanda Hui Qi Ng, et al.. (2025). Twenty-eight-day perfluorooctanoate exposure does not affect immune cell populations in naïve mice. Experimental and Molecular Pathology. 143. 104990–104990.
3.
Sahler, Julie, et al.. (2025). Cell-Free Expression of Nipah Virus Transmembrane Proteins for Proteoliposome Vaccine Design. ACS Nano. 19(23). 21290–21306.
4.
Sahler, Julie, Solomiia Khomandiak, Gary R. Whittaker, et al.. (2025). Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus. Science Advances. 11(5). eadq4545–eadq4545. 2 indexed citations
5.
Martini, Rachel, Julie Sahler, Avery August, et al.. (2024). Abstract PS18-09: The DARC side of Breast Cancer - DARC, Duffy-null and African ancestry influence in the Triple Negative Breast Cancer tumor microenvironment. Cancer Research. 84(9_Supplement). PS18–9. 1 indexed citations
6.
Buchholz, David W., Julie Sahler, Chengjin Ye, et al.. (2023). Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5. Science Advances. 9(38). eadj1736–eadj1736. 11 indexed citations
7.
Pierpont, Timothy M., et al.. (2023). Effects of PFOS and cyclophosphamide exposure on immune homeostasis in mice. Immunobiology. 228(3). 152356–152356. 6 indexed citations
8.
Buchholz, David W., Victoria Ortega, I. Abrrey Monreal, et al.. (2023). Thermophobic Trehalose Glycopolymers as Smart C‐Type Lectin Receptor Vaccine Adjuvants. Advanced Healthcare Materials. 12(19). e2202918–e2202918. 4 indexed citations
9.
Martini, Rachel, et al.. (2023). Abstract C009: Race- and TNBC-specific circulating biomarker profiles among breast cancer patients. Cancer Epidemiology Biomarkers & Prevention. 32(1_Supplement). C009–C009. 1 indexed citations
10.
Sahler, Julie, et al.. (2021). Genetic Analysis of iNKT Cell Development and Function. Methods in molecular biology. 1–12. 2 indexed citations
11.
Lannan, Katie L., Julie Sahler, Nina Kim, et al.. (2015). Breaking the Mold: Transcription Factors in the Anucleate Platelet and Platelet-Derived Microparticles. Frontiers in Immunology. 6. 48–48. 53 indexed citations
12.
Ramon, Sesquile, Steven F. Baker, Julie Sahler, et al.. (2014). The Specialized Proresolving Mediator 17-HDHA Enhances the Antibody-Mediated Immune Response against Influenza Virus: A New Class of Adjuvant?. The Journal of Immunology. 193(12). 6031–6040. 104 indexed citations
13.
Sahler, Julie, Collynn F. Woeller, & Richard P. Phipps. (2014). Microparticles Engineered to Highly Express Peroxisome Proliferator-Activated Receptor-γ Decreased Inflammatory Mediator Production and Increased Adhesion of Recipient Monocytes. PLoS ONE. 9(11). e113189–e113189. 8 indexed citations
14.
Sahler, Julie, Collynn F. Woeller, S. Spinelli, Neil Blumberg, & Richard P. Phipps. (2012). A novel method for overexpression of peroxisome proliferator‐activated receptor‐γ in megakaryocyte and platelet microparticles achieves transcellular signaling. Journal of Thrombosis and Haemostasis. 10(12). 2563–2572. 17 indexed citations
15.
Lannan, Katie L., Julie Sahler, Sherry L. Spinelli, Richard P. Phipps, & Neil Blumberg. (2012). Transfusion immunomodulation — the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Molecules and Diseases. 50(1). 61–68. 91 indexed citations
16.
Sahler, Julie, S. Spinelli, Richard P. Phipps, & Neil Blumberg. (2012). CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfusion Clinique et Biologique. 19(3). 98–103. 45 indexed citations
17.
18.
Sahler, Julie, et al.. (2011). Platelet storage and transfusions: New concerns associated with an old therapy. Drug Discovery Today Disease Mechanisms. 8(1-2). e9–e14. 37 indexed citations
19.
Sahler, Julie, Jamie J. Bernard, Sherry L. Spinelli, Neil Blumberg, & Richard P. Phipps. (2011). The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition. Thrombosis Research. 127(5). 426–434. 21 indexed citations
20.
Polesskaya, Oksana, Lisa L. Cunningham, Shimon P. Francis, et al.. (2010). Ablation of mixed lineage kinase 3 (Mlk3) does not inhibit ototoxicity induced by acoustic trauma or aminoglycoside exposure. Hearing Research. 270(1-2). 21–27. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U.J. Dumaswala Breakdown of academic impact, for papers by Rufeng Xie Breakdown of academic impact, for papers by Yanxia Sun Breakdown of academic impact, for papers by Mohammad Reza Deyhim Breakdown of academic impact, for papers by Narinder Gautam Breakdown of academic impact, for papers by Laszlo Leb Breakdown of academic impact, for papers by Su Zhang Breakdown of academic impact, for papers by Wayne M. Flye Breakdown of academic impact, for papers by Arnaud Ferraris Breakdown of academic impact, for papers by Tomoaki Doi
Rankless by CCL
2026